De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies

Misako Kunii, Hiroshi Doi, Shunta Hashiguchi, Toyojiro Matsuishi, Yasunari Sakai, Mizue Iai, Masaki Okubo, Haruko Nakamura, Keita Takahashi, Atsuko Katsumoto, Mikiko Tada, Hideyuki Takeuchi, Taro Ishikawa, Noriko Miyake, Hirotomo Saitsu, Naomichi Matsumoto, Fumiaki Tanaka

Research output: Contribution to journalArticle

Abstract

Introduction: Variants of CACNA1G, which encodes CaV3.1, have been reported to be associated with various neurological disorders. Methods: Whole-exome sequencing of genomic DNA from 348 Japanese patients with neurodevelopmental disorders and their parents was conducted, and de novo variants of CACNA1G were extracted. The electrophysiological properties of each mutant channel were investigated by voltage-clamp and current-clamp analyses of HEK293T cells overexpressing these channels. Results: Two patients diagnosed with Rett syndrome and West syndrome were found to have known pathological CACNA1G mutations reported in cerebellar ataxia cohorts: c.2881G > A, p.Ala961Thr and c.4591A > G, p.Met1531Val, respectively. One patient with Lennox–Gastaut syndrome was revealed to harbor a previously unreported heterozygous variant: c.3817A > T, p.Ile1273Phe. Clinical symptoms of the two patients with known mutations included severe developmental delay without acquisition of the ability to walk independently. The patient with a potentially novel mutation showed developmental delay, intractable seizures, and mild cerebral atrophy on MRI, but the severity of symptoms was milder than in the former two cases. Electrophysiological study using HEK293T cells demonstrated significant changes of T-type Ca2+ currents by p.Ala961Thr and p.Met1531Val SNVs, which were likely to enhance oscillation of membrane potential at low frequencies. In contrast, p.Ile1273Phe showed no significant effects in our electrophysiological evaluations, with its pathogenesis remaining undetermined. Conclusion: De novo variants of CACNA1G explain some neurodevelopmental disorders. Our study further provides information to understand the genotype–phenotype correlations of patients with CACNA1G mutations.

Original languageEnglish
Article number117047
JournalJournal of the Neurological Sciences
Volume416
DOIs
Publication statusPublished - Sep 15 2020

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies'. Together they form a unique fingerprint.

  • Cite this

    Kunii, M., Doi, H., Hashiguchi, S., Matsuishi, T., Sakai, Y., Iai, M., Okubo, M., Nakamura, H., Takahashi, K., Katsumoto, A., Tada, M., Takeuchi, H., Ishikawa, T., Miyake, N., Saitsu, H., Matsumoto, N., & Tanaka, F. (2020). De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies. Journal of the Neurological Sciences, 416, [117047]. https://doi.org/10.1016/j.jns.2020.117047